Patient with advanced osteoarthritis and indication for endoprosthetic joint replacement of the hip joint (hip TEP)
Conditions
Interventions
Group 1: Group 1:
Opti Track Athletic group: patients undergo the Fast Track program and Athletic treatment regimen during the clinical stay, with pre-rehabilitation and two-phase rehabilitation with
Sponsors
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: - Indication for primary implantation of a total hip joint endoprosthesis - age: 18 - 80 years - Patient is gainfully employed
Exclusion criteria
Exclusion criteria: - ASA 3-6 - BMI > 34 kg/m2 - Diabetes mellitus with blood glucose imbalances (hypoglycemias) - Chronic renal failure with GFR < 60 (stage III according to NKF) - Coronary artery disease with Z.n. intervention within the last 2 years or further complaints - Permanent anticoagulation with heart valve replacement - Dementia or other neurological diseases with alteration of gait (Parkinson's syndrome, myasthenia gravis, visual pathway disorders, etc.) - Anemia / hemophilia / thrombophilia with secondary DVT / LAE - Known depression / psychoaffective disorder - Chronic pain patient with long-term opioid medication - Patients with rheumatoid arthritis with expected limitation in postoperative mobilization - COPD with limitations in daily life/sleep apnea syndrome - Lack of compliance for complex treatment procedures - Language barrier - Excessive demands in the home situation during outpatient follow-up treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the score in the Hip Osteoarthritis Outcome Score including Western Ontario and McMaster Universities Osteoarthritis Index (HOOS incl. WOMAC) after 3 months, which reflects the functionality and quality of life of patients who underwent two different treatment regimens. We expect a superiority, in terms of postoperative outcome, of the Athletic group over the Classic group. The study will be considered successful if this superiority can be demonstrated. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Acquisition and comparison of HOOS at six, twelve and 24 months postoperatively. - Acquisition of other Patient Related Outcome Measurements (PROMS): University of California Los Angeles (UCLA), Harris Hip Score (HHS), Oxford Hip Score, Forgotten Joint Score (FJS), 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L), Chronic Pain Grade according to von Korff ( CPG n. v. Korff), Depression Anxiety Stress Scale (DASS) - Assessment of pain via visual analog scale (VAS) - Measurement of hip abduction force (M. gluteus medius) via dynamometer - Recording of postoperative complications - Recording of the readmission rate - Assessment of the effect of the two treatment regimens on obesity, DM type II, chronic pain syndrome - Recording of the effects of the two treatment regimens on the time of complete reintegration into the profession or on the time of resumption of the profession, respectively of the professional activity | — |
Countries
Germany
Contacts
Public ContactYvonne Noll
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift
Outcome results
None listed